The Observed Human Sperm Mutation Frequency Cannot Explain the Achondroplasia Paternal Age Effect

Total Page:16

File Type:pdf, Size:1020Kb

The Observed Human Sperm Mutation Frequency Cannot Explain the Achondroplasia Paternal Age Effect The observed human sperm mutation frequency cannot explain the achondroplasia paternal age effect Irene Tiemann-Boege*, William Navidi†‡, Raji Grewal‡§, Dan Cohn¶, Brenda Eskenaziʈ, Andrew J. Wyrobek**, and Norman Arnheim*†† *Molecular and Computational Biology Program, University of Southern California, Los Angeles, CA 90089-1340; †Department of Mathematical and Computer Sciences, Colorado School of Mines, Golden, CO 80401; §New Jersey Neuroscience Institute, 65 James Street, Edison, NJ 08820; ¶Burns and Allen Cedars-Sinai Research Institute͞Ahmanson Department of Pediatrics, Cedars-Sinai Medical Center, Los Angeles, CA 90048; ʈSchool of Public Health, University of California, Berkeley, CA 94720; and **Biology and Biotechnology Research Program, Lawrence Livermore National Laboratory, Livermore, CA 94550 Communicated by Michael S. Waterman, University of Southern California, Los Angeles, CA, September 19, 2002 (received for review August 10, 2002) The lifelong spermatogonial stem cell divisions unique to male recent data on the population incidence of sporadic achondro- germ cell production are thought to contribute to a higher muta- plasia (10, 18–20) predict the average frequency of sperm tion frequency in males. The fact that certain de novo human carrying the mutation in normal individuals will be in a range genetic conditions (e.g., achondroplasia) increase in incidence with detectable by modern molecular methods (1͞15,000 to the age of the father is consistent with this idea. Although it is 1͞70,000). Our studies on sperm DNA from men of different assumed that the paternal age effect is the result of an increasing ages suggest that the observed increase in G1138A mutation frequency of mutant sperm as a man grows older, no direct frequency cannot satisfactorily explain the exponential increase molecular measurement of the germ-line mutation frequency has in sporadic achondroplasia cases with paternal age. been made to confirm this hypothesis. Using sperm DNA from donors of different ages, we determined the frequency of the Methods nucleotide substitution in the fibroblast growth factor receptor 3 Sources of Semen Samples and DNA. Semen samples were collected (FGFR3) gene that causes achondroplasia. Surprisingly, the mag- according to protocols approved by the institutional review nitude of the increase in mutation frequency with age appears boards of the University of Southern California (USC) (60 insufficient to explain why older fathers have a greater chance of donors; mean age 40.65 years, range 18–72) and the University having a child with this condition. A number of alternatives may of California (Berkeley) and Lawrence Livermore National explain this discrepancy, including selection for sperm that carry Laboratory (LNLL) (58 donors; mean age 41.66 years, range the mutation or an age-dependent increase in premutagenic le- 22–80). At least 90% of the donors were of European ancestry. sions that remain unrepaired in sperm and are inefficiently de- Pooled human blood DNA (catalog no. 6550-1) used in the tected by the PCR assay. standards was purchased from CLONTECH. The DNA cell line (NA08859; see below) homozygous for the G1138A mutation eneticists and evolutionary biologists debate the extent to was obtained from Coriell Cell Repositories, Camden, NJ. Gwhich the lifelong spermatogonial stem cell divisions unique to male gametogenesis contribute to a higher mutation frequency in Sperm DNA Quantitation. We quantitated the number of genomes males (1–8). One source of support for the hypothesis that muta- containing the single-copy FGFR3 gene by using real-time or tions increase with spermatogonial stem cell divisions comes from kinetic PCR (kt-PCR; ref. 21). An initial denaturation step at 94°C for 10 min was followed by cycling conditions of 94°C for 40 s and the observation of certain human genetic conditions where the ␮ ϫ incidence of new mutations increases with the age of the father. 66°C for 1 min. Reactions were carried out in 50 l containing 1 Taq Gold Buffer (15 mM Tris⅐HCl͞50 mM KCl at pH 8.0), 1.25 Epidemiological studies on a number of dominantly inherited ␮ ␮ units of Taq Gold, 2 mM MgCl2,80 M of each dNTP, and 0.2 M conditions indicate that the average age of the fathers is older Ј Ј Ј among unaffected couples having a child with the condition (a forward (5 -aggagctggtggagctga-3 ) and reverse primer (5 - tgcgcaggcggcagagcgtc-3Ј), 0.2ϫ SYBR Green I (Molecular Probes), sporadic case caused by a new mutation), than the average paternal ␮ age in the population (1, 2, 4, 7). Achondroplasia, the most common and 2 M 5,6 ROX dye (Sigma). kt-PCR was performed on a form of dwarfism, is one of these conditions (9–11). Studies on GeneAmp 5700 Sequence Detection System (Applied Biosystems). sporadic achondroplasia cases have reported an exponential in- Quantitation of G1138A Mutations in Sperm DNA. crease with paternal age (1, 2, 4, 7, 10). Sperm DNA was extracted from all semen samples by using Puregene DNA In mice, a significant increase in the overall male germ cell Isolation Kits (Gentra Systems). The concentration and purity of mutation frequency as measured by the lacI assay was observed the sperm DNA samples was determined spectrophotometrically between 15 and 28 months of age (12). In humans, no direct after HaeIII or BseDI digestion to reduce the DNA viscosity. molecular measurement of how germ-line nucleotide substitu- Neither enzyme has a recognition sequence in the amplification tion frequencies change with age exists. Achondroplasia pro- target. Sperm DNA from 1͞3 of the samples was also quantitated vides a unique opportunity to directly test the relationship by using kt-PCR (see above). This process confirmed the accu- between paternal age and sperm mutation frequency at the racy of the OD measurements. molecular level. First, 97–99% of the de novo mutations leading In the first step of the assay, FGFR3 fragments containing base to this condition result from a G-to-A transition mutation at base pair 1138 (G1138A) in exon 10 of fibroblast growth factor receptor 3 (FGFR3) (13–15). The cytosine at base pair 1138 is Abbreviations: FGFR, fibroblast growth factor receptor; USC, University of Southern Cali- part of a CpG dinucleotide and, if methylated, is highly suscep- fornia; LLNL, Lawrence Livermore National Laboratory; kt-PCR, kinetic PCR; C.I., confidence tible to mutation caused by spontaneous deamination (16). interval. Second, all sporadic achondroplasia cases have been found to ‡W.N. and R.G. contributed equally to this work. inherit the G1138A mutation from their father (17). Third, ††To whom correspondence should be addressed. E-mail: [email protected]. 14952–14957 ͉ PNAS ͉ November 12, 2002 ͉ vol. 99 ͉ no. 23 www.pnas.org͞cgi͞doi͞10.1073͞pnas.232568699 Downloaded by guest on September 28, 2021 pair 1138 were amplified from 1 ␮g of sperm DNA (duplicate Sensitivity of Allele-Specific PCR. Reconstruction experiments were aliquots) with eight PCR cycles (94°C for 40 s and 66°Cfor1min) used to determine the sensitivity of the allele-specific kt-PCR preceded by a 94°C 10-min Taq Gold activation step. Each 50-␮l step. PCR product obtained by amplifying the homozygous reaction contained 1ϫ Taq Gold Buffer (15 mM Tris⅐HCl͞50 mM achondroplasia cell line DNA was mixed with blood DNA PCR KCl at pH 8.0), 1.25 units of Taq Gold (Applied Biosystems), 2 mM product. Both PCRs used the same conditions as in the first two ␮ ␮ Ј MgCl2,80 M of each dNTP, and 0.2 M forward primer (5 - steps of the assay except there was no MspI digestion. We found tgtgtatgcaggcatcctcagctcc-3Ј) and reverse primer (5Ј-tgcgcaggcg- that the ratio of one G1138A template per 600 WT templates can gcagagcgtc-3Ј). In the second step, 20 units of MspI was added to be distinguished from WT templates alone by a difference of two the amplification reaction and incubated for 30 min at 37°C PCR cycles (data not shown). This is equivalent to detecting one followed immediately by 16 additional amplification cycles. The G1138A mutant in 20,000 genomes because the MspI digestion amount of PCR product produced in these 24 cycles was confirmed in assay step two increases the ratio of mutant to WT by by kt-PCR. In the third step, two 5-␮l aliquots of a 40-fold dilution Ϸ35-fold. of each of the above duplicates were analyzed by using allele- ␮ specific kt-PCR (22). The reactions contained 0.1 ␮M of mutant- Data Collection and Analysis. In each experiment, two 1- g aliquots specific primer (5Ј-atgcaggcatcctcagctaca-3Ј) and reverse nested of sperm DNA per individual from 6–10 different donors of varying primer (5Ј-gccgccaccaccaggatgaac-3Ј), 0.8 units of Taq Gold, 1ϫ ages were analyzed. The allele-specific step for each aliquot was ␮ ϫ Taq Gold buffer, 3.5 mM MgCl2,50 M of each dNTP, 0.2 SYBR done in duplicate. The mean of the four measurements was taken Green I, and 2 ␮M 5,6 ROX dye in a total volume of 50 ␮l. An initial as the count for that sperm donor in that experiment. The final Taq Gold activation step was followed by 35 cycles of 40 s at 94°C count for any donor was calculated by taking the median of the for denaturation and 60 s at 68°C for annealing and extension. To count values obtained in different experiments. In our first statis- confirm that the PCR product was the one desired and not an tical analysis we assume that the assay produced an unbiased amplification artifact (e.g., primer-dimer), we used the GeneAmp estimate of the true counts in any sperm sample. 5700 denaturation profile function to examine every allele-specific reaction. Relationship Between Sporadic Achondroplasia Births and Mutation To avoid carryover contamination by PCR product, each step of Frequency.
Recommended publications
  • Advances in Understanding the Genetics of Syndromes Involving Congenital Upper Limb Anomalies
    Review Article Page 1 of 10 Advances in understanding the genetics of syndromes involving congenital upper limb anomalies Liying Sun1#, Yingzhao Huang2,3,4#, Sen Zhao2,3,4, Wenyao Zhong1, Mao Lin2,3,4, Yang Guo1, Yuehan Yin1, Nan Wu2,3,4, Zhihong Wu2,3,5, Wen Tian1 1Hand Surgery Department, Beijing Jishuitan Hospital, Beijing 100035, China; 2Beijing Key Laboratory for Genetic Research of Skeletal Deformity, Beijing 100730, China; 3Medical Research Center of Orthopedics, Chinese Academy of Medical Sciences, Beijing 100730, China; 4Department of Orthopedic Surgery, 5Department of Central Laboratory, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China Contributions: (I) Conception and design: W Tian, N Wu, Z Wu, S Zhong; (II) Administrative support: All authors; (III) Provision of study materials or patients: All authors; (IV) Collection and assembly of data: Y Huang; (V) Data analysis and interpretation: L Sun; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Wen Tian. Hand Surgery Department, Beijing Jishuitan Hospital, Beijing 100035, China. Email: [email protected]. Abstract: Congenital upper limb anomalies (CULA) are a common birth defect and a significant portion of complicated syndromic anomalies have upper limb involvement. Mostly the mortality of babies with CULA can be attributed to associated anomalies. The cause of the majority of syndromic CULA was unknown until recently. Advances in genetic and genomic technologies have unraveled the genetic basis of many syndromes- associated CULA, while at the same time highlighting the extreme heterogeneity in CULA genetics. Discoveries regarding biological pathways and syndromic CULA provide insights into the limb development and bring a better understanding of the pathogenesis of CULA.
    [Show full text]
  • Blueprint Genetics Craniosynostosis Panel
    Craniosynostosis Panel Test code: MA2901 Is a 38 gene panel that includes assessment of non-coding variants. Is ideal for patients with craniosynostosis. About Craniosynostosis Craniosynostosis is defined as the premature fusion of one or more cranial sutures leading to secondary distortion of skull shape. It may result from a primary defect of ossification (primary craniosynostosis) or, more commonly, from a failure of brain growth (secondary craniosynostosis). Premature closure of the sutures (fibrous joints) causes the pressure inside of the head to increase and the skull or facial bones to change from a normal, symmetrical appearance resulting in skull deformities with a variable presentation. Craniosynostosis may occur in an isolated setting or as part of a syndrome with a variety of inheritance patterns and reccurrence risks. Craniosynostosis occurs in 1/2,200 live births. Availability 4 weeks Gene Set Description Genes in the Craniosynostosis Panel and their clinical significance Gene Associated phenotypes Inheritance ClinVar HGMD ALPL Odontohypophosphatasia, Hypophosphatasia perinatal lethal, AD/AR 78 291 infantile, juvenile and adult forms ALX3 Frontonasal dysplasia type 1 AR 8 8 ALX4 Frontonasal dysplasia type 2, Parietal foramina AD/AR 15 24 BMP4 Microphthalmia, syndromic, Orofacial cleft AD 8 39 CDC45 Meier-Gorlin syndrome 7 AR 10 19 EDNRB Hirschsprung disease, ABCD syndrome, Waardenburg syndrome AD/AR 12 66 EFNB1 Craniofrontonasal dysplasia XL 28 116 ERF Craniosynostosis 4 AD 17 16 ESCO2 SC phocomelia syndrome, Roberts syndrome
    [Show full text]
  • Blueprint Genetics Comprehensive Growth Disorders / Skeletal
    Comprehensive Growth Disorders / Skeletal Dysplasias and Disorders Panel Test code: MA4301 Is a 374 gene panel that includes assessment of non-coding variants. This panel covers the majority of the genes listed in the Nosology 2015 (PMID: 26394607) and all genes in our Malformation category that cause growth retardation, short stature or skeletal dysplasia and is therefore a powerful diagnostic tool. It is ideal for patients suspected to have a syndromic or an isolated growth disorder or a skeletal dysplasia. About Comprehensive Growth Disorders / Skeletal Dysplasias and Disorders This panel covers a broad spectrum of diseases associated with growth retardation, short stature or skeletal dysplasia. Many of these conditions have overlapping features which can make clinical diagnosis a challenge. Genetic diagnostics is therefore the most efficient way to subtype the diseases and enable individualized treatment and management decisions. Moreover, detection of causative mutations establishes the mode of inheritance in the family which is essential for informed genetic counseling. For additional information regarding the conditions tested on this panel, please refer to the National Organization for Rare Disorders and / or GeneReviews. Availability 4 weeks Gene Set Description Genes in the Comprehensive Growth Disorders / Skeletal Dysplasias and Disorders Panel and their clinical significance Gene Associated phenotypes Inheritance ClinVar HGMD ACAN# Spondyloepimetaphyseal dysplasia, aggrecan type, AD/AR 20 56 Spondyloepiphyseal dysplasia, Kimberley
    [Show full text]
  • Blueprint Genetics Comprehensive Skeletal Dysplasias and Disorders
    Comprehensive Skeletal Dysplasias and Disorders Panel Test code: MA3301 Is a 251 gene panel that includes assessment of non-coding variants. Is ideal for patients with a clinical suspicion of disorders involving the skeletal system. About Comprehensive Skeletal Dysplasias and Disorders This panel covers a broad spectrum of skeletal disorders including common and rare skeletal dysplasias (eg. achondroplasia, COL2A1 related dysplasias, diastrophic dysplasia, various types of spondylo-metaphyseal dysplasias), various ciliopathies with skeletal involvement (eg. short rib-polydactylies, asphyxiating thoracic dysplasia dysplasias and Ellis-van Creveld syndrome), various subtypes of osteogenesis imperfecta, campomelic dysplasia, slender bone dysplasias, dysplasias with multiple joint dislocations, chondrodysplasia punctata group of disorders, neonatal osteosclerotic dysplasias, osteopetrosis and related disorders, abnormal mineralization group of disorders (eg hypopohosphatasia), osteolysis group of disorders, disorders with disorganized development of skeletal components, overgrowth syndromes with skeletal involvement, craniosynostosis syndromes, dysostoses with predominant craniofacial involvement, dysostoses with predominant vertebral involvement, patellar dysostoses, brachydactylies, some disorders with limb hypoplasia-reduction defects, ectrodactyly with and without other manifestations, polydactyly-syndactyly-triphalangism group of disorders, and disorders with defects in joint formation and synostoses. Availability 4 weeks Gene Set Description
    [Show full text]
  • Pfeiffer Syndrome
    Pfeiffer Syndrome *Mrs.Saranya.S Abstract: Pfeiffer syndrome is a rare genetic disorder characterized by premature fusion of certain skull bones (craniosynostosis) and other birth defects in the hands and feet. There are three subtypes of the syndrome, with Types II and III being the most severe. There is no specific treatment for Pfeiffer syndrome. Treatment is directed at improving the individual's symptoms. Pfeiffer syndrome is associated with mutations (changes) in the FGFR genes.It affects about 1 out of every 100,000 children. Pfeiffer syndrome can be inherited or can occur due to a new mutation, or change, in the involved gene. In cases of severe Pfeiffer syndrome, a new mutation is typically the cause. Key words: Pfeiffer syndrome, craniosynstosis, mutations, birth defect . INTRODUCTION Pfeiffer syndrome is a rare birth Pfeiffer syndrome type I or Classic defect ,affects the shape of a baby’s skull Pfeiffer syndrome: It includes and face.In new born, the top of the skull caraniosynstosis and “midface isn’t one solid piece. It’s actually made up of deficiency” Child with Type I Pfeiffer several bones with special joints between syndrome usually have a normal lifespan them. This allows it to expand so the brain and typical intelligence. has room to grow. Normally, the skull bones Pfeiffer syndrome type II The child come together only after the head reaches it present with cloverleaf-shaped skull due full size. In child with Pfeiffer syndrome, the to extensive fusion of bones as well as plates join together too early. The skull can’t proptosis(abnormal protrusion or expand as the brain grows, which affects the displacement of an eye or other body shape of the head and face.Pfeiffer part) and child has poor prognosis and syndrome is also referred to as severe neurological problems generally acrocephalosyndactyly type V(ACSV), with early death.
    [Show full text]
  • DSD-POI-HH Panel (V4) 29-11-2018 Versie Centrum Voor Medische Genetica Gent (122 Genen)
    H9.1-OP2-B4: Genpanel DSD-POI-HH, v5, document in voege op 03/07/2019 DSD-POI-HH panel (v4) 29-11-2018 versie Centrum voor Medische Genetica Gent (122 genen) Github commit: 053b2b9ab0c87deb7778cc9b1eeb160c044bc9dc Associated phenotype, OMIM phenotype ID, phenotype Gene OMIM gene ID mapping key and inheritance pattern AKR1C2 600450 46XY sex reversal 8, 614279 (3), Autosomal recessive AKR1C4 600451 {46XY sex reversal 8, modifier of}, 614279 (3), Autosomal recessive Persistent Mullerian duct syndrome, type I, 261550 (3), Autosomal AMH 600957 recessive Persistent Mullerian duct syndrome, type II, 261550 (3), Autosomal AMHR2 600956 recessive Hypogonadotropic hypogonadism 1 with or without anosmia ANOS1 300836 (Kallmann syndrome 1), 308700 (3), X-linked recessive Androgen insensitivity, 300068 (3), X-linked recessive; Androgen insensitivity, partial, with or without breast cancer, 312300 (3), X- linked recessive; Hypospadias 1, X-linked, 300633 (3), X-linked AR 313700 recessive; {Prostate cancer, susceptibility to}, 176807 (3), Autosomal dominant; Spinal and bulbar muscular atrophy of Kennedy, 313200 (3), X-linked recessive Epileptic encephalopathy, early infantile, 1, 308350 (3), X-linked recessive; Hydranencephaly with abnormal genitalia, 300215 (3), X- linked; Lissencephaly, X-linked 2, 300215 (3), X-linked; Mental ARX 300382 retardation, X-linked 29 and others, 300419 (3), X-linked recessive; Partington syndrome, 309510 (3), X-linked recessive; Proud syndrome, 300004 (3), X-linked Alpha-thalassemia myelodysplasia syndrome, somatic, 300448
    [Show full text]
  • Essential Genetics 5
    Essential genetics 5 Disease map on chromosomes 例 Gaucher disease 単一遺伝子病 天使病院 Prader-Willi syndrome 隣接遺伝子症候群,欠失が主因となる疾患 臨床遺伝診療室 外木秀文 Trisomy 13 複数の遺伝子の重複によって起こる疾患 挿画 Koromo 遺伝子の座位あるいは欠失等の範囲を示す Copyright (c) 2010 Social Medical Corporation BOKOI All Rights Reserved. Disease map on chromosome 1 Gaucher disease Chromosome 1q21.1 1p36 deletion syndrome deletion syndrome Adrenoleukodystrophy, neonatal Cardiomyopathy, dilated, 1A Zellweger syndrome Charcot-Marie-Tooth disease Emery-Dreifuss muscular Hypercholesterolemia, familial dystrophy Hutchinson-Gilford progeria Ehlers-Danlos syndrome, type VI Muscular dystrophy, limb-girdle type Congenital disorder of Insensitivity to pain, congenital, glycosylation, type Ic with anhidrosis Diamond-Blackfan anemia 6 Charcot-Marie-Tooth disease Dejerine-Sottas syndrome Marshall syndrome Stickler syndrome, type II Chronic granulomatous disease due to deficiency of NCF-2 Alagille syndrome 2 Copyright (c) 2010 Social Medical Corporation BOKOI All Rights Reserved. Disease map on chromosome 2 Epiphyseal dysplasia, multiple Spondyloepimetaphyseal dysplasia Brachydactyly, type D-E, Noonan syndrome Brachydactyly-syndactyly syndrome Peters anomaly Synpolydactyly, type II and V Parkinson disease, familial Leigh syndrome Seizures, benign familial Multiple pterygium syndrome neonatal-infantile Escobar syndrome Ehlers-Danlos syndrome, Brachydactyly, type A1 type I, III, IV Waardenburg syndrome Rhizomelic chondrodysplasia punctata, type 3 Alport syndrome, autosomal recessive Split-hand/foot malformation Crigler-Najjar
    [Show full text]
  • Malformation Syndromes: a Review of Mouse/Human Homology
    J Med Genet: first published as 10.1136/jmg.25.7.480 on 1 July 1988. Downloaded from Joalrn(ll of Medical Genetics 1988, 25, 480-487 Malformation syndromes: a review of mouse/human homology ROBIN M WINTER Fromii the Kennetivdy Galton Centre, Clinlicail Research Centre, Northiwick Park Hospital, Harrow, Middlesex HAI 3UJ. SUMMARY The purpose of this paper is to review the known and possible homologies between mouse and human multiple congenital anomaly syndromes. By identifying single gene defects causing similar developmental abnormalities in mouse and man, comparative gene mapping can be carried out, and if the loci in mouse and man are situated in homologous chromosome segments, further molecular studies can be performed to show that the loci are identical. This paper puts forward tentative homologies in the hope that some will be investigated and shown to be true homologies at the molecular level, thus providing mouse models for complex developmental syndromes. The mouse malformation syndromes are reviewed according to their major gene effects. X linked syndromes are reviewed separately because of the greater ease of establishing homology for these conditions. copyright. The purpose of this paper is to review the known even phenotypic similarity would be no guarantee and possible homologies between mouse and human that such genes in man and mouse are homologous". genetic malformation syndromes. Lalley and By identifying single gene defects causing similar following criteria for developmental abnormalities in mouse and man, McKusick' recommend the http://jmg.bmj.com/ identifying gene homologies between species: comparative gene mapping can be carried out, and if (1) Similar nucleotide or amino acid sequence.
    [Show full text]
  • Discover Dysplasias Gene Panel
    Discover Dysplasias Gene Panel Discover Dysplasias tests 109 genes associated with skeletal dysplasias. This list is gathered from various sources, is not designed to be comprehensive, and is provided for reference only. This list is not medical advice and should not be used to make any diagnosis. Refer to lab reports in connection with potential diagnoses. Some genes below may also be associated with non-skeletal dysplasia disorders; those non-skeletal dysplasia disorders are not included on this list. Skeletal Disorders Tested Gene Condition(s) Inheritance ACP5 Spondyloenchondrodysplasia with immune dysregulation (SED) AR ADAMTS10 Weill-Marchesani syndrome (WMS) AR AGPS Rhizomelic chondrodysplasia punctata type 3 (RCDP) AR ALPL Hypophosphatasia AD/AR ANKH Craniometaphyseal dysplasia (CMD) AD Mucopolysaccharidosis type VI (MPS VI), also known as Maroteaux-Lamy ARSB syndrome AR ARSE Chondrodysplasia punctata XLR Spondyloepimetaphyseal dysplasia with joint laxity type 1 (SEMDJL1) B3GALT6 Ehlers-Danlos syndrome progeroid type 2 (EDSP2) AR Multiple joint dislocations, short stature and craniofacial dysmorphism with B3GAT3 or without congenital heart defects (JDSCD) AR Spondyloepimetaphyseal dysplasia (SEMD) Thoracic aortic aneurysm and dissection (TADD), with or without additional BGN features, also known as Meester-Loeys syndrome XL Short stature, facial dysmorphism, and skeletal anomalies with or without BMP2 cardiac anomalies AD Acromesomelic dysplasia AR Brachydactyly type A2 AD BMPR1B Brachydactyly type A1 AD Desbuquois dysplasia CANT1 Multiple epiphyseal dysplasia (MED) AR CDC45 Meier-Gorlin syndrome AR This list is gathered from various sources, is not designed to be comprehensive, and is provided for reference only. This list is not medical advice and should not be used to make any diagnosis.
    [Show full text]
  • A Germ-Line-Selective Advantage Rather Than an Increased Mutation Rate Can Explain Some Unexpectedly Common Human Disease Mutations
    A germ-line-selective advantage rather than an increased mutation rate can explain some unexpectedly common human disease mutations Soo-Kyung Choi, Song-Ro Yoon, Peter Calabrese*†, and Norman Arnheim*† Molecular and Computational Biology Program, University of Southern California, 1050 Childs Way, Los Angeles, CA 90089-2910 Edited by James F. Crow, University of Wisconsin, Madison, WI, and approved April 16, 2008 (received for review February 7, 2008) Two nucleotide substitutions in the human FGFR2 gene (C755G or mutation hot-spot model (the nucleotide has a higher-than- C758G) are responsible for virtually all sporadic cases of Apert average chance of undergoing a base substitution) at one of these syndrome. This condition is 100–1,000 times more common than sites (C755G). Positive selection for spermatogonial cells car- genomic mutation frequency data predict. Here, we report on the rying a newly arisen mutation is an alternative explanation (4–6, C758G de novo Apert syndrome mutation. Using data on older 11, 12) for an apparently high nucleotide substitution frequency. donors, we show that spontaneous mutations are not uniformly In our earlier study (6), we were unable to reject the selection distributed throughout normal testes. Instead, we find foci where hypothesis as an explanation for the C755G data. C758G mutation frequencies are 3–4 orders of magnitude greater In this work, we studied the other common de novo Apert than the remaining tissue. We conclude this nucleotide site is not nucleotide substitution (C758G). We examined four individual a mutation hot spot even after accounting for possible Luria– testes from three older individuals and two testes from younger Delbruck ‘‘mutation jackpots.’’ An alternative explanation for such donors.
    [Show full text]
  • Improving Diagnosis and Treatment of Craniofacial Malformations Utilizing Animal Models
    CHAPTER SEVENTEEN From Bench to Bedside and Back: Improving Diagnosis and Treatment of Craniofacial Malformations Utilizing Animal Models Alice F. Goodwin*,†, Rebecca Kim*,†, Jeffrey O. Bush*,{,},1, Ophir D. Klein*,†,},},1 *Program in Craniofacial Biology, University of California San Francisco, San Francisco, California, USA †Department of Orofacial Sciences, University of California San Francisco, San Francisco, California, USA { Department of Cell and Tissue Biology, University of California San Francisco, San Francisco, California, USA } Department of Pediatrics, University of California San Francisco, San Francisco, California, USA } Institute for Human Genetics, University of California San Francisco, San Francisco, California, USA 1Corresponding authors: e-mail address: [email protected]; [email protected] Contents 1. Models to Uncover Genetics of Cleft Lip and Palate 460 2. Treacher Collins: Proof of Concept of a Nonsurgical Therapeutic for a Craniofacial Syndrome 467 3. RASopathies: Understanding and Developing Treatment for Syndromes of the RAS Pathway 468 4. Craniosynostosis: Pursuing Genetic and Pharmaceutical Alternatives to Surgical Treatment 473 5. XLHED: Developing Treatment Based on Knowledge Gained from Mouse and Canine Models 477 6. Concluding Thoughts 481 Acknowledgments 481 References 481 Abstract Craniofacial anomalies are among the most common birth defects and are associated with increased mortality and, in many cases, the need for lifelong treatment. Over the past few decades, dramatic advances in the surgical and medical care of these patients have led to marked improvements in patient outcomes. However, none of the treat- ments currently in clinical use address the underlying molecular causes of these disor- ders. Fortunately, the field of craniofacial developmental biology provides a strong foundation for improved diagnosis and for therapies that target the genetic causes # Current Topics in Developmental Biology, Volume 115 2015 Elsevier Inc.
    [Show full text]
  • Date Due Date Due Date Due
    PLACE ll RETURN BOX to roman this chockout from your mood. TO AVOID FINES Mom on or baton dd. duo. DATE DUE DATE DUE DATE DUE MSU In An Affirmative Action/Equal Opponfirmy Inflation mm: SCREENING FOR MUTATIONS IN PAX3 AND MITF IN WAARDENBURG SYNDROME AND WAARDENBURG SYNDROME-LIKE INDIVIDUALS By Melisa Lynn Carey A THESIS Submitted to Michigan State University in partial fulfillment of the requirements for a degree of MASTER OF SCIENCE Department of Zoology 1 996 ABSTRACT SCREENING FOR MUTATIONS IN PAX3 AND MITF IN WAARDENBURG SYNDROME AND WAARDENBURG SYNDROME-LIKE INDIVIDUALS BY Melisa L. Carey Waardenburg Syndrome (WS) is an autosomal dominant disorder characterized by pigmentary and facial anomalies and congenital deafness. Mutations causing WS have been reported in PAX3 and MITF. The goal of this study was to characterize the molecular defects in 33 unrelated WS individuals. Mutation detection was performed using Single Strand Conformational Polymorphism (SSCP) analysis and sequencing methods. Among the 33 WS individuals, a total of eight mutations were identified, seven in PAX3 and one in MITF. In this study, one of the eight mutations was identified and characterized in PAX3 exon seven in a WSI family (UoM1). The proband of UoM1 also has Septo-Optic Dysplasia. In a large family (MSU22) with WS-Iike dysmorphology and additional craniofacial anomalies, linkage was excluded to PAX3 and no mutations were identified in MITF. Herein I review the status of mutation detection in our proband screening set and add to the understanding of the role of PAX3 and MITF in development by exploring new phenotypic characteristics associated with WS.
    [Show full text]